Technology
New On Robinhood
Health

NGM Biopharmaceuticals

$14.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.39 (-2.55%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell NGM and other stocks, options, ETFs, and crypto commission-free!

About NGM

NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. Read More The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.

Employees
Headquarters
South San Francisco, California
Founded
2008
Market Cap
984.04M
Price-Earnings Ratio
Dividend Yield
Average Volume
117.15K
High Today
$15.56
Low Today
$14.71
Open Price
$15.29
Volume
128.75K
52 Week High
$18.75
52 Week Low
$12.00

Collections

Technology
New On Robinhood
Health
Biotechnology
Therapy
2019 IPO
US
North America

NGM Earnings

-$1.21
-$0.85
-$0.49
-$0.13
Q1 2019
Q2 2019
Estimated
Actual
-$0.13 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.